User profiles for Abbas Tuli

Abbas Tuli, MD, MPH

Department of Radiology, Icahn School of Medicine at Mount Sinai
Verified email at mountsinai.org
Cited by 182

Maternal stress, preterm birth, and DNA methylation at imprint regulatory sequences in humans

AC Vidal, SEB Neelon, Y Liu, AM Tuli… - Genetics & …, 2014 - journals.sagepub.com
In infants exposed to maternal stress in utero, phenotypic plasticity through epigenetic events
may mechanistically explain increased risk of preterm birth (PTB), which confers increased …

[HTML][HTML] Comparison of PET/CT and PET/MR imaging and dosimetry of yttrium-90 (90Y) in patients with unresectable hepatic tumors who have received intra-arterial …

K Knešaurek, A Tuli, E Kim, S Heiba, L Kostakoglu - EJNMMI physics, 2018 - Springer
Background The aim of our study was to compare 90 Y dosimetry obtained from PET/MRI
versus PET/CT post-therapy imaging among patients with primary or metastatic hepatic tumors. …

Quantitative comparison of pre-therapy 99mTc-macroaggregated albumin SPECT/CT and post-therapy PET/MR studies of patients who have received intra-arterial …

K Knešaurek, A Tuli, SD Pasik, S Heiba… - European Journal of …, 2018 - Elsevier
Objective The aim of our study was to compare yttrium -90 ( 90 Y) dosimetry obtained from
pre-therapy 99m Tc-macroaggregated albumin (MAA) SPECT/CT versus post-therapy PET/…

[HTML][HTML] Albinism and disease causing pathogens in Tanzania: Are alleles that are associated with OCA2 being maintained by balancing selection?

AM Tuli, RK Valenzuela, E Kamugisha, MH Brilliant - Medical Hypotheses, 2012 - Elsevier
Oculocutaneous albinism type 2 (OCA2) is present at significantly higher frequencies in sub-Saharan
African populations compared to populations in other regions of the world. In …

Comparison of Y-90 dosimetry derived from post-therapy PET/CT and bremsstrahlung SPECT imaging

K Knesaurek, A Tuli, E Kim, L Kostakoglu - 2016 - Soc Nuclear Med
1893 Objectives The aim of our study was to compare Y-90 dosimetry obtained from
bremsstrahlung SPECT (bSPECT) and PET/CT post-therapy Y-90 imaging. Methods : In a …

Comparison of sequential PET/CT and PET/MR in previously treated multiple myeloma patients.

A Tuli, JB Ayache, S Parekh, K Thamnirat, A Chari… - 2017 - Soc Nuclear Med
187 Objectives: FDG PET/CT (PET/CT) plays an important role in multiple myeloma (MM)
management; specifically for staging, detecting extramedullary disease, evaluating therapeutic …

Impact and Potential Pitfalls of Ga-68 DOTATATE PET/CT

Y Ahmad, A Tuli, M Muhleman, U Sen, S Gavane… - 2018 - Soc Nuclear Med
1221 Introduction: Neuroendocrine tumors (NETs) are a heterogeneous class of rare tumors
which have been increasing in incidence, partly due to improved diagnosis.[1] Most NETs …

Radiologist's take home pointers on F-18 fluciclovine (Axumin) PET/CT imaging

M Muhleman, A Tuli, Y Ahmad, U Sen, S Gavane… - 2018 - Soc Nuclear Med
1228 Introduction: Prostate cancer (PCa) is the most commonly diagnosed non-cutaneous
malignancy among men in the United States (US) representing 9.6% of all new US cancer …

Accuracy of Prediction for Y-90 Glass Microsphere Radioembolization in Hepatocellular Carcinoma Using IntrahepaticTc-99m MAA planning SPECT/CT

S Heiba, S Gavane, A Tuli, H Mehdikhani, Y Ahmad… - 2018 - Soc Nuclear Med
1377 Objectives: Intrahepatic Tc-99m macro-aggregated (MAA) is usually used to determine
the radiation dose to lungs and assess for abnormal abdominal shunting prior to Y-90 …

Comparison of PET/MRI and PET/CT imaging and dosimetry in patients who have received intra-arterial radioembolization therapy with 90Y microspheres

K Knesaurek, A Tuli, S Heiba, L Kostakoglu - 2018 - Soc Nuclear Med
598 Objectives: The aim of our study was to compare 90 Y dosimetry obtained from PET/MRI
and PET/CT post-therapy imaging among patients with primary or metastatic hepatic tumors…